Cyclocarbamate derivatives as progesterone receptor modulators
US7488822B2 · kind B2 · utility
9Cited by
80References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 29, 2004 |
| Grant date | Feb 10, 2009 |
| Priority date | — |
| Expiry date | Jun 6, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention provides compounds of Formula (I):wherein R1 and R2 are independent substituents or are fused to form spirocyclic rings; R3, RC, and R4 are as defined herein; and R5 is a substituted benzene ring or a substituted five or six membered heterocyclic ring having in its backbone 1, 2, or 3 heteroatoms including O, S, SO, SO2 or NR6; or pharmaceutically acceptable salt thereof, as well as pharmaceutical compositions and methods using the compounds as antagonists of the progesterone receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.